Skip to content
Home/Companies/Biotech/Sim&Cure

Sim&Cure

Biotech·France·Active
Entry
–
Hold
–
Status
Active

Who owns Sim&Cure?

Sim&Cure is a French Biotech company, currently owned by Elaia Partners since 2019 and Lazard Elaia Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Lazard Elaia Capital
Most recent investor
Lazard Elaia Capital
Lazard Elaia Capital Fund I · 2025 · Growth
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

2 ownership periods

Active
Co-held by Elaia Partners and Lazard Elaia Capital since 2019.
Elaia Partners
Elaia PartnersActive
2019 · present(7yr) · Elaia Delta Fund · 2017 · VC
Lazard Elaia Capital
Lazard Elaia CapitalActive
present · Lazard Elaia Capital Fund I · 2025 · Growth

More from Lazard Elaia Capital Fund I

Other portfolio companies in the same fund.

Adomik
Adomik
Active
AdTechFrance
Armis
Armis
Active
AdTechFrance
Arsen
Arsen
Active
CybersecurityFrance
Case Law Analytics
Active
FintechFrance
Cien
Cien
Active
USA
CodeNotary
CodeNotary
Active
CybersecurityUSA

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Sim&Cure?

Sim&Cure is currently owned by Elaia Partners and Lazard Elaia Capital, through Lazard Elaia Capital Fund I, since 2019.

When did Elaia Partners and 1 other acquire Sim&Cure?

Elaia Partners and 1 other acquired Sim&Cure in 2019.

Who has owned Sim&Cure over time?

Sim&Cure has been through 2 private-equity ownership periods: Elaia Partners · via Elaia Delta Fund · since 2019; Lazard Elaia Capital · via Lazard Elaia Capital Fund I.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue